KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

The evolution of treatment for pediatric advanced stage classic Hodgkin lymphoma - a narrative literature review.

Nisha Shariff, Foo Jen Chun, Susan K Parsons, David C Hodgson

Leuk Lymphoma 66(12) 2155-2167

PMID40776670
PMCID-
DOI10.1080/10428194.2025.2531154
发表日期2025-08-08
摘要

摘要

Recent trials introducing novel immunotherapy into the treatment of advanced-stage pediatric classic Hodgkin lymphoma (cHL) suggest that cure rates will exceed 90%. Consequently, more than ever there is a need to minimize the toxicity of treatment and ensure that survivors experience a quality of life unimpaired by late effects. We performed a structured literature review to analyze frontline trials of advanced pediatric cHL, the impact of toxicity of treatments and on health-related quality of life. A total of 6 clinical trials were included, 4 randomized phase 3 trials, 1 non-randomized phase 3 trial and 1 phase 2 trial. One longitudinal study and 5 retrospective registry-based studies were included in the health-related quality of life review. The use of novel systemic treatments has significantly improved outcomes in advanced- pediatric cHL. However, new challenges arise to better understand quality of life outcomes among survivors, and to make new drugs more widely accessible.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。